← Open Payments lookup

MARY SCHEXNAYDRE: Open Payments

NPI 1942794367 · NEW ORLEANS, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,325 in 45 payments from 8 companies in 2025. Trend: 2023 $1,177 · 2024 $565 · 2025 $1,325

Food & beverage: $1,325
CompanyPaymentsAmount
Janssen Pharmaceuticals, Inc7$266
E.R. Squibb & Sons, L.L.C.10$222
Teva Pharmaceuticals USA, Inc.6$222
Alkermes, Inc.10$218
Otsuka America Pharmaceutical, Inc.5$186
Neurocrine BioSciences, Inc.5$163
Vanda Pharmaceuticals Inc.1$33
Luye Pharma (USA) Ltd.1$15

Products named: COBENFY, ARISTADA, SPRAVATO, UZEDY, INGREZZA, REXULTI, INVEGA, AUSTEDO XR.

Industry payments across LA — which companies pay providers there.